China Alexipharmic Drugs Market Analysis

China Alexipharmic Drugs Market Analysis


$ 3999

China's Alexipharmic drugs market size was valued at $xx Bn in 2022 and is estimated to expand at a CAGR of 6.20% from 2022-30 and will reach $xx Bn in 2030. The market is segmented by product type, indication, route of administration, end-user, and distribution channel. The China Alexipharmic Drugs market will grow because the Chinese government and healthcare providers are increasing their efforts to raise public awareness about poisoning and the availability of antidotes. The key market players are Beijing Kawin Technology Share-Holding (CHN), Yino Pharma Limited (CHN), and others.

ID: IN10CNPH004 CATEGORY: Pharmaceuticals GEOGRAPHY: China AUTHOR: Chandani Patel

Buy Now

China Alexipharmic Drugs Market Executive Summary

China's Alexipharmic drugs market size was valued at $xx Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 6.20% from 2022 to 2030 and will reach $xx Bn in 2030. China has a large and growing demand for alexipharmic drugs due to the country's high rate of poisoning. According to a report by the Chinese Center for Disease Control and Prevention (CDC), there were over 300,000 reported cases of acute poisoning in China in 2019. The majority of these cases were caused by pesticide exposure, but other common causes of poisoning included drug overdoses and food poisoning.

As a result of this high demand, the market for alexipharmic drugs in China is expected to grow in the coming years. In terms of trends, there is a growing interest in developing new and more effective antidotes for different types of poisonings. For example, in 2018, Chinese researchers developed a new antidote for cyanide poisoning using a nanoparticle-based delivery system. There is also a focus on improving the availability of antidotes in rural areas, where access to medical care can be limited. Overall, the demand for alexipharmic drugs in China is driven by the high rate of poisoning in the country, and the market for these drugs is expected to continue to grow in the coming years as new products and technologies are developed.

Market Dynamics

Market Growth Drivers

  1. Increasing Poisoning Cases: The high number of poisoning cases in China is a major driver of the demand for alexipharmic drugs, which is expected to continue growing due to the ongoing presence of toxins in the environment, including pesticides, heavy metals, and other chemicals
  2. Increasing Public Awareness: The Chinese government and healthcare providers are increasing their efforts to raise public awareness about poisoning and the availability of antidotes, which is expected to drive demand for alexipharmic drugs in the coming years
  3. Government Support: The Chinese government has taken steps to improve the availability of antidotes in rural areas, and is investing in the development of new antidote products to meet the growing demand for these drugs
  4. Technological Advances: Advances in technology and research are leading to the development of new and more effective antidotes, which is expected to drive demand in the alexipharmic drugs market in China

Market Restraints

  1. High Cost of Treatment: The cost of antidotes and related medical care can be high, which can limit access to these treatments for some patients
  2. Complex Regulatory Environment: The regulatory environment in China can be complex, which can slow the development and approval of new antidote products
  3. Lack of Standardization: There is currently a lack of standardization in the production and distribution of antidote products in China, which can make it difficult for patients and healthcare providers to access and use these drugs effectively
  4. Limited Access to Medical Care: Despite government efforts to improve access to medical care in rural areas, many people in China still do not have access to adequate healthcare, which can limit the availability of antidotes in these areas

Competitive Landscape

Key Players

  • Beijing Kawin Technology Share-Holding (CHN)
  • Yino Pharma Limited (CHN)
  • Yangtze River Pharmaceutical Group (CHN)
  • Zhejiang Hisun Pharmaceutical (CHN)
  • Shanghai Fosun Pharmaceutical (Group) (CHN)
  • Sichuan Kelun Pharmaceutical (CHN)
  • Sino Biopharmaceutical Limited (CHN)
  • North China Pharmaceutical Group Corporation (CHN)
  • Jiangsu Hengrui Medicine (CHN)
  • Lepu Medical Technology (Beijing) (CHN)
  • Pfizer Inc.
  • Eli Lilly and Company
  • Merck & Co., Inc.
  • GlaxoSmithKline plc.
  • Roche Holding AG
  • Novartis International AG
  • Bayer AG
  • Teva Pharmaceutical Industries Ltd.

Notable Deals

In 2020, the Chinese company Lepu Medical Technology (Beijing) Co., Ltd. acquired the German medical device company Heal Force Bio-Meditech Holdings Limited. Lepu Medical Technology is involved in the production and distribution of a range of medical products, including alexipharmic drugs.

Healthcare Policies and Regulatory Landscape

The Chinese government has a rigorous regulatory system in place to ensure the safety and efficacy of pharmaceutical products, including alexipharmic drugs. The China National Medical Products Administration (NMPA) is the regulatory authority responsible for the approval and supervision of pharmaceutical products in China. Companies that want to manufacture or import alexipharmic drugs must obtain approval from the NMPA. The approval process typically involves preclinical and clinical studies, as well as a review of manufacturing and quality control procedures.

Reimbursement Scenario

In China, the government plays a significant role in determining the reimbursement of medical treatments, including alexipharmic drugs. The National Healthcare Security Administration (NHSA) is responsible for setting reimbursement rates for drugs and medical procedures. The NHSA typically negotiates with pharmaceutical companies to determine the price of drugs, and these negotiated prices are then used to determine the reimbursement rates for patients.

In general, reimbursement for alexipharmic drugs in China is available through the national healthcare insurance system. However, the level of reimbursement may vary depending on the specific drug and the patient's insurance coverage. In addition, some patients may still be required to pay a portion of the cost of the drug out of pocket, particularly if the drug is expensive or not widely available.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Alexipharmic Drugs Market Segmentation

By Product Type (Revenue, USD Billion):

The product type segment contributed the largest share to the Alexipharmic Drugs Market in 2021; this segment is projected to grow at the highest CAGR from 2022 to 2030.

  • Tetraethylthiuram Disulfide
  • Glutathione
  • EDTA
  • Penicillamine
  • Methylene Blue
  • Diethylenetriaminepentaacetic Acid
  • 2 Aminoethanethiol
  • Sodium Nitrite
  • Dimercapto Propanol
  • Triethylenetetramine
  • Na-DMS
  • Naloxone
  • Naltrexone
  • Sodium Thiosulfate
  • Pyraloxime
  • Pralidoxime Iodide
  • Flumazenil

By Indication (Revenue, USD Billion):

  • Alcoholic Overdose
  • Opioid Overdose
  • Cyanide Poisoning
  • Others

By Route of Administration (Revenue, USD Billion):

  • Oral
  • Parenteral
  • Others

By End User (Revenue, USD Billion):

  • Hospitals
  • Specialty Clinics
  • Others

By Distribution Channel (Revenue, USD Billion):

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 16 March 2023
Updated by: Riya Doshi

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up